MX2008001643A - Metodo para conservar la funcion de celulas productoras de insulina. - Google Patents
Metodo para conservar la funcion de celulas productoras de insulina.Info
- Publication number
- MX2008001643A MX2008001643A MX2008001643A MX2008001643A MX2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A MX 2008001643 A MX2008001643 A MX 2008001643A
- Authority
- MX
- Mexico
- Prior art keywords
- insulin
- producing cells
- preserving
- function
- furthering
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 10
- 102000004877 Insulin Human genes 0.000 title abstract 5
- 108090001061 Insulin Proteins 0.000 title abstract 5
- 229940125396 insulin Drugs 0.000 title abstract 5
- 230000001419 dependent effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70429505P | 2005-08-01 | 2005-08-01 | |
| PCT/US2006/030014 WO2007016600A2 (en) | 2005-08-01 | 2006-08-01 | Method of preserving the function of insulin-producing cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008001643A true MX2008001643A (es) | 2008-04-07 |
Family
ID=37561086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008001643A MX2008001643A (es) | 2005-08-01 | 2006-08-01 | Metodo para conservar la funcion de celulas productoras de insulina. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1915171B1 (enExample) |
| JP (2) | JP2009503093A (enExample) |
| CN (1) | CN101232899A (enExample) |
| AU (1) | AU2006275424B2 (enExample) |
| BR (1) | BRPI0614489A2 (enExample) |
| CA (1) | CA2617226A1 (enExample) |
| DK (1) | DK1915171T3 (enExample) |
| ES (1) | ES2439455T3 (enExample) |
| MX (1) | MX2008001643A (enExample) |
| WO (1) | WO2007016600A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| JP4681231B2 (ja) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | 吸入装置 |
| ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
| HUE025151T2 (en) | 2004-08-23 | 2016-01-28 | Mannkind Corp | Diceto-piperazine salts for drug delivery |
| MX373000B (es) | 2005-09-14 | 2020-05-21 | Mannkind Corp | Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas. |
| CN104383546B (zh) | 2006-02-22 | 2021-03-02 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| MY155524A (en) | 2008-06-13 | 2015-10-30 | Mannkind Corp | A dry powder inhaler and system for drug delivery |
| EP2609954B1 (en) | 2008-06-20 | 2021-12-29 | MannKind Corporation | An interactive apparatus for real-time profiling of inhalation efforts |
| TWI494123B (zh) | 2008-08-11 | 2015-08-01 | Mannkind Corp | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| SI2379100T1 (sl) * | 2009-01-08 | 2015-02-27 | Mannkind Corporation | Zdravljenje hiperglikemije z GLP-1 |
| MX2011009251A (es) * | 2009-03-04 | 2011-11-18 | Mannkind Corp | Sistema mejorado de suministro de farmaco en polvo seco. |
| US8538707B2 (en) | 2009-03-11 | 2013-09-17 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| AU2010259943C1 (en) | 2009-06-12 | 2016-03-03 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| JP5784622B2 (ja) | 2009-11-03 | 2015-09-24 | マンカインド コーポレ−ション | 吸入活動をシミュレートするための装置及び方法 |
| RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
| MX353285B (es) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Paquete de blister para cartuchos farmaceuticos. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| HK1201475A1 (en) | 2011-10-24 | 2015-09-04 | Mannkind Corporation | Methods and compositions for treating pain |
| AU2013289957B2 (en) | 2012-07-12 | 2017-02-23 | Mannkind Corporation | Dry powder drug delivery systems and methods |
| US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
| US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
| BR122019026637B1 (pt) | 2013-07-18 | 2023-09-26 | Mannkind Corporation | Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco |
| CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| US9898585B2 (en) | 2014-01-31 | 2018-02-20 | Aseko, Inc. | Method and system for insulin management |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
| JP6989262B2 (ja) | 2014-10-27 | 2022-01-05 | アセコー インコーポレイテッド | 皮下外来患者管理 |
| JP7109155B2 (ja) | 2015-06-04 | 2022-07-29 | キッコーマン株式会社 | フラビン結合型グルコースデヒドロゲナーゼを用いたグルコースの測定方法 |
| EP3337402B1 (en) | 2015-08-20 | 2026-01-07 | Glytec, LLC | Diabetes management therapy advisor |
| CN110187123B (zh) * | 2019-05-06 | 2022-07-22 | 天津医科大学总医院 | 一种糖尿病早期诊断生物标志物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0975328A1 (en) * | 1997-04-02 | 2000-02-02 | Purdue Research Foundation | Method for oral delivery of proteins |
| ES2395096T3 (es) * | 1999-06-29 | 2013-02-08 | Mannkind Corporation | Purificación y estabilización de agentes farmacéuticos a base de péptidos y proteínas |
| GB0217382D0 (en) * | 2002-07-26 | 2002-09-04 | Pfizer Ltd | Process for making orally consumable dosage forms |
| EP1605895A4 (en) * | 2003-03-06 | 2011-08-24 | Emisphere Tech Inc | ORAL INSULIN THERAPIES AND PROTOCOL |
| US20050153874A1 (en) * | 2004-01-12 | 2005-07-14 | Mannkind Corporation | Method of reducing serum proinsulin levels in type 2 diabetics |
-
2006
- 2006-08-01 EP EP06789148.1A patent/EP1915171B1/en not_active Expired - Lifetime
- 2006-08-01 BR BRPI0614489-6A patent/BRPI0614489A2/pt not_active Application Discontinuation
- 2006-08-01 CA CA002617226A patent/CA2617226A1/en not_active Abandoned
- 2006-08-01 JP JP2008525132A patent/JP2009503093A/ja active Pending
- 2006-08-01 DK DK06789148.1T patent/DK1915171T3/da active
- 2006-08-01 MX MX2008001643A patent/MX2008001643A/es not_active Application Discontinuation
- 2006-08-01 CN CNA2006800283625A patent/CN101232899A/zh active Pending
- 2006-08-01 WO PCT/US2006/030014 patent/WO2007016600A2/en not_active Ceased
- 2006-08-01 AU AU2006275424A patent/AU2006275424B2/en not_active Ceased
- 2006-08-01 ES ES06789148.1T patent/ES2439455T3/es not_active Expired - Lifetime
-
2015
- 2015-01-08 JP JP2015002059A patent/JP2015091854A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1915171B1 (en) | 2013-11-20 |
| AU2006275424A1 (en) | 2007-02-08 |
| JP2009503093A (ja) | 2009-01-29 |
| JP2015091854A (ja) | 2015-05-14 |
| WO2007016600A2 (en) | 2007-02-08 |
| ES2439455T3 (es) | 2014-01-23 |
| BRPI0614489A2 (pt) | 2011-03-29 |
| WO2007016600A3 (en) | 2007-05-31 |
| AU2006275424B2 (en) | 2013-01-10 |
| CA2617226A1 (en) | 2007-02-08 |
| CN101232899A (zh) | 2008-07-30 |
| DK1915171T3 (da) | 2013-12-09 |
| EP1915171A2 (en) | 2008-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007016600A3 (en) | Method of preserving the function of insulin-producing cells | |
| DK2321321T3 (da) | Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister | |
| WO2009023566A3 (en) | Method of treating autoimmune disease with mesenchymal stem cells | |
| MY160041A (en) | Compositions and methods for treating parasitic infections | |
| EP2705850A3 (en) | Super fast-acting insulin compositions | |
| IL194438A (en) | Diarrhylthiohydantoin Compounds, Pharmaceuticals Containing Them, Syntheses Methods and In Vitro Methods for Contacting them with Mammalian Cells | |
| EP2727998A3 (en) | Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells | |
| PH12012501054A1 (en) | Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders | |
| TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| SG10201406300YA (en) | L-ornithine phenyl acetate and methods of making thereof | |
| MX348735B (es) | Celulas madre mesenquimales que expresan los receptores tnf-alfa. | |
| WO2006017134A3 (en) | Preprimitive streak and mesendoderm cells | |
| CL2008002227A1 (es) | Compuestos derivados de 4-[(8r)-4-amino-5-oxo-7,8-dihidrorimido[5,4-f][1,4]oxazepin-6(5h)-il]fenilo sustituido; su composicion farmaceutica; y uso de los compuestos en el tratamiento de la diabetes de tipo 2, utiles particularmente para tratar la obesidad. | |
| WO2009086471A3 (en) | Synergistic antiparasitic compositions and screening methods | |
| HRP20110969T1 (en) | Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure | |
| TW200800987A (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
| BRPI0506839A (pt) | composições e métodos para induzir a cardiomiogênese | |
| EA200701029A1 (ru) | Новая композиция для облегчения человеческих родов | |
| IL205696A0 (en) | Heterocyclic derivatives, compositions comprising the same and uses thereof | |
| EP2048227A3 (en) | Methods for proliferating stem cells | |
| CR9853A (es) | Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion | |
| MX2007011493A (es) | Modalidades antiinflamatorias. | |
| UY29236A1 (es) | 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización. | |
| WO2011019867A3 (en) | Dietary supplements and methods for treating pain and inflammation | |
| EP1940377A4 (en) | TOPICAL AEROSPECTIVE COMPOSITIONS OF N, 2,3-TRIMETHYL-2-ISOPROPYLBUTAMIDE AND METHOD OF USE THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |